Search Results - "Christoulas, Dimitrios"

Biology and treatment of myeloma related bone disease by Terpos, Evangelos, Christoulas, Dimitrios, Gavriatopoulou, Maria

“…Myeloma bone disease (MBD) is the most common complication of multiple myeloma (MM), resulting in skeleton-related events (SREs) such as severe bone pain,…”
Get full text

Sickle-cell disease and the heart: review of the current literature by Voskaridou, Ersi, Christoulas, Dimitrios, Terpos, Evangelos

“…Summary Sickle cell disease (SCD) is an inherited chronic haemolytic anaemia whose clinical manifestations arise from the tendency of the haemoglobin to…”
Get full text

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients by Katodritou, Eirini, Terpos, Evangelos, Symeonidis, Argiris S., Pouli, Anastasia, Kelaidi, Charikleia, Kyrtsonis, Marie‐Christine, Kotsopoulou, Maria, Delimpasi, Sosana, Christoforidou, Anna, Giannakoulas, Nikolaos, Viniou, Nora‐Athina, Stefanoudaki, Ekaterini, Hadjiaggelidou, Christina, Christoulas, Dimitrios, Verrou, Evgenia, Gastari, Vassiliki, Papadaki, Sofia, Polychronidou, Genovefa, Papadopoulou, Athina, Giannopoulou, Evlambia, Kastritis, Efstathios, Kouraklis, Alexandra, Konstantinidou, Pavlina, Anagnostopoulos, Achilles, Zervas, Konstantinos, Dimopoulos, Meletios A.

“…Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia characterized by the presence of bone or extramedullary plasma cell tumors. The treatment of choice…”
Get full text

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment by Dimopoulos, Meletios A., Christoulas, Dimitrios, Roussou, Maria, Kastritis, Efstathios, Migkou, Magdalini, Gavriatopoulou, Maria, Matsouka, Charis, Mparmparoussi, Despoina, Psimenou, Erasmia, Grapsa, Irini, Efstathiou, Eleni, Terpos, Evangelos

“…Objectives:  Lenalidomide and dexamethasone (LenDex) is an active regimen for relapsed/refractory multiple myeloma (MM). However, there is limited data for the…”
Get full text

Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome by TERPOS, Evangelos, ASLI, Bouchra, CHRISTOULAS, Dimitrios, BROUET, Jean-Claude, KASTRITIS, Efstathios, RYBOJAD, Michel, BENGOUFA, Djaouida, DIMOPOULOS, Meletios A, FERMAND, Jean Paul

“…Schnitzler syndrome is a rare plasma cell disorder the pathogenesis of which is still not fully understood. We evaluated the circulating levels of four major…”
Get full text

Pulmonary hypertension in patients with sickle cell/ β thalassemia : incidence and correlation with serum n-terminal pro-brain natriuretic peptide concentrations by VOSKARIDOU, Ersi, TSETSOS, George, TSOUTSIAS, Antonios, SPYROPOULOU, Evgenia, CHRISTOULAS, Dimitrios, TERPOS, Evangelos

“…Pulmonary hypertension (PH) is increasingly observed in sickle cell disease (SCD) and beta-thalassemia (beta-thal), but there is no information on its…”
Get full text

Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration by Terpos, Evangelos, Katodritou, Eirini, Tsiftsakis, Evangelos, Kastritis, Efstathios, Christoulas, Dimitrios, Pouli, Anastasia, Michalis, Eurydiki, Verrou, Evgenia, Anargyrou, Konstantinos, Tsionos, Konstantinos, Dimopoulos, Meletios A, Zervas, Konstantinos

“…On behalf of the Greek Myeloma Study Group Correspondence: Evangelos Terpos, Department of Hematology and Medical Research, 251 General Air Force Hospital, 3…”
Get full text

Low Bone Mineral Density and High Bone Turnover in Patients With Non‐Hodgkin's Lymphoma (NHL) Who Receive Frontline Therapy: Results of a Multicenter Prospective Study by Anargyrou, Konstantinos, Fotiou, Despina, Vassilakopoulos, Theodoros P., Christoulas, Dimitrios, Makras, Polyzois, Dimou, Maria, Ntanasis‐Stathopoulos, Ioannis, Masouridou, Stavroula, Angelopoulou, Maria K., Papatheodorou, Athanasios, Tsionos, Konstantinos, Panayiotidis, Panayiotis, Dimopoulos, Meletios A., Terpos, Evangelos

“…Chemotherapy associated osteoporosis is a severe problem in patients with malignant diseases as it increases the risk for fractures and deteriorates quality of…”
Get full text

Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration by Voskaridou, Ersi, Christoulas, Dimitrios, Xirakia, Charoula, Varvagiannis, Konstantinos, Boutsikas, Georgios, Bilalis, Antonios, Kastritis, Efstathios, Papatheodorou, Athanasios, Terpos, Evangelos

“…1 Thalassemia Center, Laikon General Hospital, Athens 2 Department of Medical Research, 251 General Air Force Hospital, Athens 3 Department of Clinical…”
Get full text

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry by Diamantopoulos, Panagiotis, Koumbi, Dafni, Kotsianidis, Ioannis, Pappa, Vasiliki, Symeonidis, Argiris, Galanopoulos, Athanasios, Zikos, Panagiotis, Papadaki, Helen A., Panayiotidis, Panayiotis, Dimou, Maria, Hatzimichael, Eleftheria, Vassilopoulos, George, Delimpasis, Susan, Mparmparousi, Despoina, Papageorgiou, Sotirios, Variami, Eleni, Kyrtsonis, Marie‐Christine, Megalakaki, Aekaterini, Kotsopoulou, Maria, Repousis, Panagiotis, Adamopoulos, Ioannis, Kontopidou, Flora, Christoulas, Dimitrios, Kourakli, Alexandra, Tsokanas, Dimitrios, Konstantinos Papoutselis, Menelaos, Kyriakakis, Georgios, Viniou, Nora‐Athina

“…In patients with myelodysplastic syndrome (MDS), the prognostic significance of chromosome 17 abnormalities has not yet been fully elucidated, except for…”
Get full text

Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial by Voskaridou, Ersi, Christoulas, Dimitrios, Konstantinidou, Marialena, Tsiftsakis, Evangelos, Alexakos, Panagiotis, Terpos, Evangelos

Get full text

Effects of proteasome inhibitors on bone cancer by Terpos, Evangelos, Christoulas, Dimitrios

“…Bone metastasis is a frequent complication of cancer, occurring in up to 70% of patients with advanced breast or prostate cancer, while bone disease is also…”
Get full text

Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib by Anargyrou, Konstantinos, Terpos, Evangelos, Vassilakopoulos, Theodoros P, Pouli, Anastasia, Sachanas, Sotirios, Tzenou, Tatiana, Masouridis, Stavroula, Christoulas, Dimitrios, Angelopoulou, Maria K, Dimitriadou, Evangelia M, Kalpadakis, Christina, Tsionos, Konstantinos, Panayiotidis, Panayiotis, Dimopoulos, Meletios A, Pangalis, Gerassimos A, Kyrtsonis, Marie-Christine, on behalf of Greek Myeloma Study Group

“…1 Department of Haematology, 251 General Air Force Hospital, Athens 2 Department of Haematology, National and Kapodistrian University of Athens’ School of…”
Get full text

The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) by Voskaridou, Ersi, Christoulas, Dimitrios, Bilalis, Antonios, Plata, Eleni, Varvagiannis, Konstantinos, Stamatopoulos, George, Sinopoulou, Klio, Balassopoulou, Aggeliki, Loukopoulos, Dimitris, Terpos, Evangelos

“…The aim of this prospective study was to evaluate the long-term efficacy and safety of hydroxyurea (HU) in patients with sickle cell disease (SCD). Thirty-four…”
Get full text

Quantitative Diffusion-weighted Imaging of the Bone Marrow: An Adjunct Tool for the Diagnosis of a Diffuse MR Imaging Pattern in Patients with Multiple Myeloma by Koutoulidis, Vassilis, Fontara, Sophia, Terpos, Evangelos, Zagouri, Flora, Matsaridis, Dimitris, Christoulas, Dimitrios, Panourgias, Evangelia, Kastritis, Efstathios, Dimopoulos, Meletios A, Moulopoulos, Lia A

“…Purpose To evaluate the apparent diffusion coefficients (ADCs) of magnetic resonance (MR) imaging patterns in the bone marrow of patients with multiple myeloma…”
Get full text

Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single‐agent chelation therapies by Voskaridou, Ersi, Christoulas, Dimitrios, Terpos, Evangelos

Get full text

Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: Reduction post-bortezomib monotherapy by Terpos, Evangelos, Christoulas, Dimitrios, Katodritou, Eirini, Bratengeier, Cornelia, Gkotzamanidou, Maria, Michalis, Eurydiki, Delimpasi, Sosana, Pouli, Anastasia, Meletis, John, Kastritis, Efstathios, Zervas, Konstantinos, Dimopoulos, Meletios A.

“…Sclerostin is a Wingless and Int‐1 inhibitor, which is produced by osteocytes and inhibits osteoblast‐driven bone formation. Sclerostin is implicated in the…”
Get full text

Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma by Terpos, Evangelos, Katodritou, Eirini, Symeonidis, Argiris, Zagouri, Flora, Gerofotis, Antonis, Christopoulou, Georgia, Gavriatopoulou, Maria, Christoulas, Dimitrios, Ntanasis‐Stathopoulos, Ioannis, Kourakli, Alexandra, Konstantinidou, Pavlina, Kastritis, Efstathios, Dimopoulos, Meletios A.

“…There is limited data regarding the efficacy and safety of lenalidomide, adriamycin and dexamethasone (RAD) combination on newly diagnosed multiple myeloma…”
Get full text

Activin-A is elevated in patients with thalassemia major and double heterozygous sickle cell/beta-thalassemia and correlates with markers of hemolysis and bone mineral density by Voskaridou, Ersi, Ntanasis-Stathopoulos, Ioannis, Christoulas, Dimitrios, Dimopoulou, Maria, Komninaka, Veroniki, Repa, Konstantina, Papatheodorou, Athanasios, Terpos, Evangelos

“…Despite the advances in the management of hemoglobinopathies, further insight into disease pathophysiology is necessary to improve our therapeutic approach…”
Get full text

The Chronic Kidney Disease Epidemiology Collaboration cystatin C (CKD-EPI-CysC) equation has an independent prognostic value for overall survival in newly diagnosed patients with symptomatic multiple myeloma; is it time to change from MDRD to CKD-EPI-CysC equations? by Terpos, Evangelos, Christoulas, Dimitrios, Kastritis, Efstathios, Katodritou, Eirini, Pouli, Anastasia, Michalis, Eurydiki, Papassotiriou, Ioannis, Dimopoulos, Meletios A.

“…Objectives The estimation of glomerular filtration rate (eGFR) in multiple myeloma (MM) is based on equations that use serum creatinine (sCr), such as the…”
Get full text